TO: Pharmacies, Physicians, Physician Assistants, Nurse Practitioners, Oral Surgeons,
Optometrists, Dentists, FQHCs, RHCs, Mental Health Service Providers and Nursing
RE: Pharmacy/Preferred Drug Program Updates
Effective July 1, 2013,
the Alabama Medicaid Agency will:
1. Make changes to its current policy regarding compound prescriptions and
reimbursement for bulk products (i.e., powders) used in compounded prescriptions.
The changes are outlined below:
Bulk products will no longer be covered for adults age 21 and older (some exceptions may
apply). Selected medically necessary bulk products will remain covered for children.
Claims for bulk powders must be submitted as a compound claim.
Compounding time will no longer be reimbursed by Alabama Medicaid.
The maximum payable amount for a compounded product will be $200 per claim. Overrides
for medical necessity may be approved. Requests for overrides should be submitted to Health Information Designs, Inc. (HID).
For information regarding compound claims and bulk powders, see section 27.2.5 of the Alabama Medicaid Provider Manual at
2. No longer require prior authorization (PA) for payment of generic lansoprazole.
name Prevacid will continue to require prior authorization (PA).
3. Require prior authorization for payment of generic azelastine nasal spray.
Astelin will be preferred and available with no PA necessary.
Use Dispense as Written (DAW) Code of 9 for brand Astelin. Generic versions of the drug
will be non-preferred and will require prior authorization. DAW Code of 9 indicates the following: Substitution Allowed by Prescriber but Plan Requests Brand - Patient's Plan Requested Brand Product to be Dispensed.
4. Update the Preferred Drug List (PDL) to reflect the recent Pharmacy and Therapeutics
(P&T) Committee’s recommendations as well as quarterly updates.
The updates are listed
For additional PDL and coverage information, visit our drug look-up site at
The PA request form and criteria booklet, as well as a link for a PA request form that can be completed and submitted electronically online, can be found on the Agency’s website at and should be utilized by the prescribing physician or the dispensing pharmacy when requesting a PA. Providers requesting PAs by mail or fax should send requests to:
Health Information Designs (HID)
Medicaid Pharmacy Administrative Services
P. O. Box 3210 Auburn, AL 36832-3210
Incomplete PA requests or those failing to meet Medicaid criteria will be denied. If the prescribing
physician believes medical justification should be considered, the physician must document this on
the form or submit a written letter of medical justification along with the prior authorization form to
HID. Additional information may be requested. Staff physicians will review this information.
Policy questions concerning this provider notice should be directed to the Pharmacy Program at (334)
242-5050. Questions regarding prior authorization procedures should be directed to the HID help
desk at 1-800-748-0130.
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. BINGO GROUP HOLDINGS LIMITED
General Information: Office Address: Email: [email protected] FAX: 617-876-5148 Education: 1984 B.A. Williams College 1992 Ph.D. Department of Physiology & Cellular Biophysics Columbia University – Presbyterian Medical Center, 1993 M.D. Columbia University – Presbyterian Medical Center Postdoctoral Training: PGY 1 medical intern Department of Internal Medicine